F. Caussade et A. Cloarec, EFFECT OF TIENOXOLOL, A NEW DIURETIC BETA-BLOCKING AGENT, ON URINARY PROSTAGLANDIN EXCRETION IN THE RAT, British Journal of Pharmacology, 109(1), 1993, pp. 278-284
1 The effects of tienoxolol, (ethyl 2-[3-[(1, 1 yl)amino]-2-hydroxypro
poxyl-5-[(2-thienylcarbonyl) amino] benzoate, hydrochloride), a novel
drug exhibiting both diuretic and beta-adrenoceptor blocking propertie
s, were investigated on urinary 6-keto-prostaglandin F1alpha (6-keto-P
GF1alpha) and PGE2 excretion in the rat and compared to those of refer
ence diuretic (furosemide) and beta-adrenoceptor antagonists (acebutol
ol, propranolol). Since tienoxolol was shown to bind to A1 and A2 aden
osine receptors, the action of theophylline was also evaluated. 2 Tien
oxolol (8-128 mg kg-1, p.o.) induced a dose-related increase of 6-keto
-PGF1alpha excretion from 32 mg kg-1 but a significant elevation of ur
inary PGE2 levels was only reached after administration of 128 mg kg-1
. However, renal prostaglandin concentrations were not modified by tie
noxolol. 3 Furosemide (32 mg kg-1) displayed a strong diuretic activit
y but did not enhance 6-keto-PGF1alpha excretion. Likewise, the latter
was unaffected by acebutolol and propranolol (I 28 mg kg-1) and no si
gnificant diuresis was observed following administration of these two
beta-blocking agents. Theophylline (64 mg kg-1), like tienoxolol, was
able to induce both diuresis and urinary prostaglandin excretion. Furt
hermore, they bound with similar affinities to A1 and A2 adenosine rec
eptors. This led to the suggestion that a relationship between P1-puri
noceptors, prostaglandin release, diuresis and natriuresis could exist
. 4 Oral co-administration of NECA (0.2 mg kg-1 with tienoxolol marked
ly reduced the urinary 6-keto-PGF1alpha excretion observed when tienox
olol was administered alone. However, neither diuresis nor natriuresis
were modified, demonstrating that the proposed relationship was unten
able. 5 In conclusion, PGI2 Probably does not participate in the diure
tic and natriuretic activity of tienoxolol. The increase of urinary 6-
keto-PGF1alpha excretion may result not only from the haemodynamic pro
perties of the drug but also from the rise of the urinary flow induced
by tienoxolol.